Melphalan, Lenalidomide and Dexamethasone for the Treatment of Immunoglobulin Light Chain Amyloidosis: Results of a Phase II Trial
Haematologica - Italy
doi 10.3324/haematol.2012.075192
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 9, 2012
Authors
Publisher
Ferrata Storti Foundation (Haematologica)